This Cannabis Giant Has European Targets in Its Sights Ahead of U.S. Legalization Frenzy, CEO Says

By Jack Denton

Cannabis deals in Europe will help pot giant Aphria build up a war chest ahead of an expected frenzy of mergers and acquisitions in the U.S., the company’s chair and chief executive told Barron’s ahead of the group’s earnings on Monday.

High-margin medical cannabis agreements in Europe represent critical waypoints on Aphria’s road to conquer the U.S., bolstering the company’s balance sheet and putting it on firm footing with European regulators, said Irwin Simon.  

To read more:

Post a Comment

Your email address will not be published. Required fields are marked *

*